| RS1816889095 |
CYP11B1
|
Health Risk |
Pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS1816900835 |
CYP11B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glucocorticoid-remediable aldosteronism, Glucocorticoid-remediable aldosteronism |
| RS1816901292 |
CYP11B1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS181690344 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS1816926704 |
CYP11B1
|
Health Risk |
Pathogenic |
— |
| RS1816943902 |
CYP11B1
|
Health Risk |
Pathogenic |
— |
| RS181694819 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS1816948809 |
CYP11B1
|
Health Risk |
Pathogenic |
— |
| RS1816949224 |
CYP11B1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS1816952189 |
CYP11B1
|
Health Risk |
Likely pathogenic |
— |
| RS181695922 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1816966972 |
CYP11B1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS1816968040 |
CYP11B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Glucocorticoid-remediable aldosteronism |
| RS1816980417 |
CYP11B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Glucocorticoid-remediable aldosteronism |
| RS181698127 |
ACTA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 6 |
| RS181699780 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS1817027997 |
PUF60
|
Health Risk |
Pathogenic |
8q24.3 microdeletion syndrome, 8q24.3 microdeletion syndrome |
| RS1817052708 |
FGFR1
|
Health Risk |
Likely pathogenic |
Pfeiffer syndrome, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS1817058474 |
CYP11B1
|
Health Risk |
Pathogenic |
— |
| RS181711422 |
DSE
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, musculocontractural type 2 |
| RS181711509 |
ITGA7
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to integrin alpha-7 deficiency, Congenital muscular dystrophy due to integrin alpha-7 deficiency |
| RS1817121202 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1817122287 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1817122724 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1817123754 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS181717727 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS181719686 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS181720619 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 2, Fraser syndrome 2 |
| RS181726819 |
PSEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1U, Alzheimer disease 3 |
| RS181727939 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1817280576 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Pfeiffer syndrome |
| RS181729570 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS181729783 |
CFI
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly |
| RS181731184 |
CACNA2D4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal cone dystrophy 4, Retinal cone dystrophy 4 |
| RS181731943 |
LMF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Lipase deficiency |
| RS1817344544 |
DGAT1
|
Health Risk |
Pathogenic |
— |
| RS1817352625 |
DGAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital diarrhea 7 with exudative enteropathy, Congenital diarrhea 7 with exudative enteropathy |
| RS181736797 |
BBS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 |
| RS181737266 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1817405711 |
TG
|
Health Risk |
Pathogenic |
— |
| RS1817415840 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS181743799 |
BTD
|
Health Risk |
Conflicting classifications of pathogenicity |
Biotinidase deficiency, Biotinidase deficiency |
| RS181748854 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS181749265 |
CDON
|
Health Risk |
Conflicting classifications of pathogenicity |
Holoprosencephaly 11, Holoprosencephaly 11 |
| RS1817497939 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1817497974 |
GLDC
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS181750463 |
FDFT1
|
Health Risk |
Conflicting classifications of pathogenicity |
FDFT1-related disorder, FDFT1-related disorder |
| RS1817544823 |
CYP11B2
|
Health Risk |
Pathogenic |
CYP11B2-related disorder, CYP11B2-related disorder |
| RS1817553996 |
CYP11B2
|
Health Risk |
Conflicting classifications of pathogenicity |
Corticosterone methyloxidase type 2 deficiency, Corticosterone 18-monooxygenase deficiency |
| RS1817555980 |
GLDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1817559457 |
CYP11B2
|
Health Risk |
Pathogenic |
— |
| RS1817561200 |
VLDLR
|
Health Risk |
Pathogenic |
— |
| RS1817574696 |
CYP11B2
|
Health Risk |
Pathogenic |
— |
| RS1817576999 |
CYP11B2
|
Health Risk |
Pathogenic |
— |
| RS1817580833 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal syndrome, type III |
| RS1817583687 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS181758389 |
RPGRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 13, Leber congenital amaurosis 6 |
| RS1817584930 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1817596770 |
CYP11B2
|
Health Risk |
Pathogenic |
— |
| RS1817601054 |
CYP11B2
|
Health Risk |
Conflicting classifications of pathogenicity |
Corticosterone 18-monooxygenase deficiency, Corticosterone methyloxidase type 2 deficiency |
| RS1817612031 |
CYP11B2
|
Health Risk |
Pathogenic/Likely pathogenic |
Corticosterone 18-monooxygenase deficiency, Corticosterone methyloxidase type 2 deficiency |
| RS181762580 |
NFU1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple mitochondrial dysfunctions syndrome 1, Multiple mitochondrial dysfunctions syndrome 1 |
| RS1817625926 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1817626324 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1817626453 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS181762689 |
USH1C
|
Health Risk |
Pathogenic |
— |
| RS1817657601 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1817660485 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS181766682 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS181769913 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1DD |
| RS181779633 |
AIRE
|
Health Risk |
Conflicting classifications of pathogenicity |
Polyglandular autoimmune syndrome, type 1 |
| RS1817811676 |
SPAG1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 28, Primary ciliary dyskinesia 28 |
| RS181782027 |
ALS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 2, juvenile |
| RS1817866954 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817867776 |
EXT1
|
Health Risk |
Likely pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817868370 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817870176 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817870237 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817871338 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817872132 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817872593 |
EXT1
|
Health Risk |
Pathogenic |
— |
| RS1817872999 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817873443 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817873582 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817873681 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817873963 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817874249 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817875217 |
EXT1
|
Health Risk |
Likely pathogenic |
Ovarian cancer, Ovarian cancer |
| RS1817876107 |
EXT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817876148 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817876363 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817877188 |
EXT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817878703 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817879125 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817879250 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817879832 |
EXT1
|
Health Risk |
Likely pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817880834 |
EXT1
|
Health Risk |
Pathogenic |
— |
| RS1817881036 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817881221 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817881722 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |